FMP
PCRX icon

Financial Management Professionals’s Pacira BioSciences PCRX Stock Holding History

Financial Management Professionals’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-790
Closed -$42K – 1038
2022
Q3 		$42K Hold
790
– – 0.01% 240
2022
Q2 		$46K Sell
790
-110
-12% -$7.21K 0.01% 235
2022
Q1 		$69K Buy
+900
New +$60K 0.02% 210

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Financial Management Professionals's PCRX Position: Q4 2022 in Review

Financial Management Professionals sold out of Pacira BioSciences (PCRX) in Q4 2022, closing a stake of 790 shares — an estimated $42K sold.

Financial Management Professionals first reported a position in PCRX in Q1 2022 and held it in 3 quarters. The position peaked at $69K in Q1 2022. 273 funds tracked by Wall St. Rank hold PCRX as of Q4 2022.

  • Financial Management Professionals reported no remaining Pacira BioSciences position as of Q4 2022 after selling out during the quarter.
  • Financial Management Professionals sold 790 Pacira BioSciences shares in Q4 2022, an estimated $42K.
  • Financial Management Professionals first reported a position in Pacira BioSciences in Q1 2022 and held it in 3 quarters.
  • Financial Management Professionals's Pacira BioSciences position peaked at $69K in Q1 2022.
  • 273 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2022.

Based on Financial Management Professionals's 13F filing for Q4 2022, filed 11 Jan 2023.